Dr. Graig Suvannavejh - is a senior biotechnology and biopharmaceuticals analyst and Managing Director at Mizuho Securities, and is based in NYC. He brings over 20 years of sell-side healthcare equity research and investment banking experience, working at both bulge bracket and healthcare-dedicated boutique banks, covering the global pharmaceuticals, specialty pharmaceuticals, generic pharmaceuticals and biotechnology sectors, with prior firms including Goldman Sachs, JP Morgan, Jefferies, and UBS, among other. Graig also brings operational experience, having held business development/BD and corporate strategy roles at the global biopharmaceutical companies AbbVie and Biogen, and in addition, he previously consulted for Alzheon, a privately held, biotechnology company focused on the development of novel treatments for Alzheimer's disease. He holds a PhD in Neuroscience from Northwestern University, and an undergraduate Biology and a Master's in Physiology and Biophysics degree, both from Georgetown University.